Literature DB >> 26614957

Chemical and Radiation-Associated Jaw Lesions.

Temitope T Omolehinwa1, Sunday O Akintoye2.   

Abstract

Osteonecrosis of the jaw is a major public health concern throughout the world. Use of radiotherapy for head and neck cancer and bone antiresorptives and antiangiogenic agents have increased its incidence. Medication-related osteonecrosis of the jaw is more common relative to other types of osteonecrosis. Osteoradionecrosis occurs despite better treatment planning and shielding to minimize collateral damage to bone. Other related necrotic lesions are secondary to usage of recreational drugs and steroids. This article provides comprehensive information about these different types of bone necrosis; provides the readers with radiographic diagnostic criteria and updates on current theories on pathophysiology of osteonecrosis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemical; Damage; Diseases; Medication-related osteonecrosis; Necrosis; Osteoradionecrosis; Radiation; Recreational drug

Mesh:

Substances:

Year:  2016        PMID: 26614957      PMCID: PMC4762602          DOI: 10.1016/j.cden.2015.08.009

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  45 in total

Review 1.  Bevacizumab.

Authors:  Filis Kazazi-Hyseni; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2010-08-05

Review 2.  Osteoradionecrosis: an update.

Authors:  C Madrid; M Abarca; K Bouferrache
Journal:  Oral Oncol       Date:  2010-05-10       Impact factor: 5.337

3.  Effects of antiresorptive agents on osteomyelitis: novel insights into the pathogenesis of osteonecrosis of the jaw.

Authors:  Dan Li; Kirill Gromov; Steven T Proulx; Chao Xie; Jie Li; Daniel P Crane; Kjeld Søballe; Regis J O'Keefe; Hani A Awad; Lianping Xing; Edward M Schwarz
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

4.  Human bone marrow stromal cells display variable anatomic site-dependent response and recovery from irradiation.

Authors:  Monika Damek-Poprawa; Derek Stefanik; Lawrence M Levin; Sunday O Akintoye
Journal:  Arch Oral Biol       Date:  2010-04-07       Impact factor: 2.633

5.  Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease? A meta-analysis of randomized controlled trials.

Authors:  Davide Mauri; Antonis Valachis; Nikolaos P Polyzos; Lamprini Tsali; Dimitris Mavroudis; Vassilis Georgoulias; Giovanni Casazza
Journal:  J Natl Compr Canc Netw       Date:  2010-03       Impact factor: 11.908

6.  Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.

Authors:  Chang-Ta Chiu; Wei-Fan Chiang; Ching-Ya Chuang; Sung-Wen Chang
Journal:  J Oral Maxillofac Surg       Date:  2010-05       Impact factor: 1.895

7.  Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.

Authors:  Matthew S Epstein; Fredrick W Wicknick; Joel B Epstein; James R Berenson; Meir Gorsky
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-11

8.  Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw.

Authors:  Franca Dore; Luca Filippi; Matteo Biasotto; Silvia Chiandussi; Fabio Cavalli; Roberto Di Lenarda
Journal:  J Nucl Med       Date:  2008-12-17       Impact factor: 10.057

9.  Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases.

Authors:  Matti Aapro; Fred Saad; Luis Costa
Journal:  Oncologist       Date:  2010-11-04

10.  The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK.

Authors:  C Cooper; M Steinbuch; R Stevenson; R Miday; N B Watts
Journal:  Osteoporos Int       Date:  2009-06-23       Impact factor: 4.507

View more
  7 in total

1.  The association with xerostomia from sialadenitis and the jaw osteonecrosis in head and neck cancer population: a nationwide cohort study.

Authors:  Yi-Fang Huang; Chih-Hsin Muo; Chun-Hao Tsai; Shih-Ping Liu; Chung-Ta Chang
Journal:  Clin Oral Investig       Date:  2018-05-03       Impact factor: 3.573

2.  Impact of communication between physicians and dentists on the incidence of jaw osteonecrosis caused by bone anti-resorptives.

Authors:  Sunday O Akintoye; Elliot V Hersh
Journal:  Curr Med Res Opin       Date:  2016-05-18       Impact factor: 2.580

3.  Mandibular osteonecrosis following herpes zoster infection: Report of a rare case with a literature review.

Authors:  Emilie Faure; Marc Engels-Deutsch; Elena-Adinisia Paraschiv; Eric Gérard; Rémi Curien
Journal:  Clin Case Rep       Date:  2021-05-24

4.  Development of an experimental model for radiation-induced inhibition of cranial bone regeneration.

Authors:  Hong-Moon Jung; Jeong-Eun Lee; Seoung-Jun Lee; Jung-Tae Lee; Tae-Yub Kwon; Tae-Geon Kwon
Journal:  Maxillofac Plast Reconstr Surg       Date:  2018-11-22

5.  Osteoradionecrosis prevalence and associated factors: A ten years retrospective study.

Authors:  I-F Pereira; R-T Firmino; H-C Meira; B-C-E Vasconcelos; V-R-A-S Noronha; V-R Santos
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-11-01

Review 6.  Schemes for Drug-Induced Treatment of Osteonecrosis of Jaws with Particular Emphasis on the Influence of Vitamin D on Therapeutic Effects.

Authors:  Filip Michalak; Sylwia Hnitecka; Marzena Dominiak; Kinga Grzech-Leśniak
Journal:  Pharmaceutics       Date:  2021-03-08       Impact factor: 6.321

7.  Conditioned Medium from Bone Marrow Mesenchymal Stem Cells Restored Oxidative Stress-Related Impaired Osteogenic Differentiation.

Authors:  Ragda Saleem; Samih Mohamed-Ahmed; Rammah Elnour; Ellen Berggreen; Kamal Mustafa; Niyaz Al-Sharabi
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.